You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
I know that this has been developed to account for PTA specific biases. However, can this software be used to analyze MDA scWGS data? I saw that this was done in the pre-print describing this tool.
Thanks!
The text was updated successfully, but these errors were encountered:
Although SCAN2 can be applied to MDA data, one should exercise caution when interpreting the results. As we show in our preprint, there is a fair amount of MDA-induced artifacts that are difficult to detect. SCAN2's mutation signature-based rescue is fundamentally an additive process - that is, additional somatic mutation calls are made based on mutation signatures. This does not address MDA artifacts: one would need to do the opposite process (i.e., remove somatic mutation calls based on mutation signature) to do that. Indels in MDA data seem to be similar to SNVs. There is a fair number of artifacts with a somewhat specific artifact signature.
Despite this important disclaimer, we do recommend using SCAN2 over SCAN-SNV for MDA data since SCAN2 contains most of SCAN-SNV functionality but is easier to use and more up-to-date.
I know that this has been developed to account for PTA specific biases. However, can this software be used to analyze MDA scWGS data? I saw that this was done in the pre-print describing this tool.
Thanks!
The text was updated successfully, but these errors were encountered: